Xiaohui Ding
Papers
4
Total Citations
31
H-Index
3
About
Dr. Xiaohui Ding is a pioneering urologic surgeon whose research is redefining the surgical management of urologic cancers, particularly renal cell carcinoma (RCC) and prostate cancer. Based at the Chinese People's Liberation Army General Hospital, Dr. Ding's work centers on advanced surgical techniques and precision diagnostics. A landmark contribution is the first prospective trial demonstrating the feasibility of radical prostatectomy without prior biopsy in select patients, guided by PSMA PET/CT and multiparametric MRI—a paradigm-shifting approach that could spare patients unnecessary procedures (19 citations). In RCC, Dr. Ding has made seminal contributions to managing tumor thrombus, analyzing a large cohort of 350 patients to reveal how histological subtypes impact survival, and pioneering virtual-reality and robot-assisted techniques for inferior vena cava thrombectomy. With a high-volume series of 309 robot-assisted nephrectomies and venous thrombectomies, Dr. Ding has established key indications and strategies that improve long-term outcomes. This body of work, combining innovative imaging, minimally invasive robotics, and rigorous outcomes analysis, positions Dr. Ding as a leader in advancing personalized, less invasive surgical care for complex urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4